Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 1,761

Document Document Title
WO/2018/112649A1
The present application relates to amidine substituted analogues as shown in formula I and uses thereof as an anti-inflammatory agent and/or for the treatment of an immunological disorder or of an inflammatory bowel disease including ulc...  
WO/2018/108998A1
The present invention relates to compounds of the formula (I), in particular to phenylamidines of the formula (I), to a process for their preparation, to the use of phenylamidines of the formula (I) according to the invention for control...  
WO/2018/108992A2
The present invention relates to compounds of the formula (I), in particular to phenoxyphenylamidines of the formula (I), to a process for their preparation, to the use of phenoxyphenylamidines of the formula (I) according to the inventi...  
WO/2018/102262A1
The invention provides novel inhibitors or inactivators of protein arginine deiminases, pharmaceutical compositions and methods of use thereof. The invention also relates to molecular probes based on such compounds and methods of use the...  
WO/2018/091430A1
Compounds of the formula (I), wherein R1, R2, R3, R4 and R5 are as defined in claim 1. Furthermore, the present invention relates to agrochemical compositions which comprise compounds of formula (I), to preparation of these compositions,...  
WO/2018/088079A1
Provided is a starting material for thin film formation which comprises a compound represented by general formula (1). (In the formula, R1 denotes a straight- or branched-chain alkyl group having 1-5 carbon atoms, R2 denotes a hydrogen a...  
WO/2018/069833A1
The present invention relates to stable amorphous form of sacubitril valsartan trisodium complex and its solid dispersion compounds, processes for their preparation and pharmaceutical composition comprising the same. The present inventio...  
WO/2018/069842A1
This invention relates to 4-substituted phenylamine derivatives of the general formula (I), wherein R1 to R8 and A have the meanings as defined in description. The invention further relates to methods for their preparation and use of sai...  
WO/2018/069841A1
This invention relates to 4-substituted phenylamine derivatives of the general formula (I), wherein R1 to R9 and A have the meanings as defined in description. The invention further relates to methods for their preparation and use of sai...  
WO/2017/222468A1
A carbon dioxide (CO2) sensitive dielectric nanocomposite, a capacitive CO2 sensor and a method for fabrication of the capacitive CO2 sensor are provided. The CO2 sensitive dielectric nanocomposite includes a low molecular weight organic...  
WO/2017/155092A1
The present invention provides a composition for controlling a plant disease comprising a tetrazolinone compound represented by formula (1) wherein X1 represents a halogen atom etc., and X2 represents a C1-C3 alkyl group etc., and at lea...  
WO/2017/105449A1
Embodiments of the present disclosure describe methods of synthesis of amidines, amidine-metal complexes, thin metal films formed using amidine-metal complexes on semiconductor devices, and semiconductor devices and systems with thin met...  
WO/2017/102635A1
Compounds of the formula (I) wherein R1, R2, R3, R4, R5, R6, R7, R8 and X are as defined in claim 1. Furthermore, the present invention relates to agrochemical compositions which comprise compounds of formula (I), to preparation of these...  
WO/2017/093495A2
The present invention relates to a novel process for the preparation of Ν,Ν'-unsubstituted carboxamidines or a salt thereof. The present invention further relates to a novel process for the preparation of N, N'-unsubstituted carboxamid...  
WO/2017/093495A3
The present invention relates to a novel process for the preparation of Ν,Ν'-unsubstituted carboxamidines or a salt thereof. The present invention further relates to a novel process for the preparation of N, N'-unsubstituted carboxamid...  
WO/2017/067839A1
Compounds of the formula (I), wherein R1, R2, R3, Q1, Q2, Q3, R4, R5, R6, R7, R8 and R9 are as defined in claim 1. Furthermore, the present invention relates to agrochemical compositions which comprise compounds of formula (I), to prepar...  
WO/2017/067837A1
Compounds of the formula (I) wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, A, X and Y are as defined in claim 1. Furthermore, the present invention relates to agrochemical compositions which comprise compounds of formula (I), to preparatio...  
WO/2017/042700A1
The present invention provides solid forms comprising valsartan and sacubitril. The present invention provides solid salt forms comprising valsartan and sacubitril. The present invention further provides an amorphous solid salt form comp...  
WO/2017/005710A1
The present invention relates phenoxyhalogenphenylamidmes of the general formula (I), to a process for their preparation, to the use of the amidines according to the invention for controlling unwanted microorganisms and also to an agroch...  
WO/2016/202742A1
The present invention relates to halogen-substituted phenoxyphenylamidines of the general formula (I), to a process for their preparation, to the use of the amidines according to the invention for controlling unwanted microorganisms and ...  
WO/2016/202688A1
The present invention relates to halogen-substituted phenoxyphenylamidines of the general formula (I), to a process for their preparation, to the use of the amidines according to the invention for controlling unwanted microorganisms and ...  
WO/2016/121260A1
Provided are: an acid alkylating agent represented by general formula (1), by which a compound having at least one acidic group selected from among a sulfonic acid group, a phosphoric acid group and a phenolic hydroxyl group is acid alky...  
WO/2016/105448A1
This disclosure provides compounds and compositions for use as analgesics and for the treatment of various conditions, such as pain, headaches, allodynia, and fibromyalgia. The disclosure also provides compounds that are ligands, and in ...  
WO/2016/073738A2
Compounds that modulate the oxidoreductase enzyme indoleamine 2,3- dioxygenase, and compositions containing the compounds, are described herein. The use of such compounds and compositions for the treatment and/or prevention of a diverse ...  
WO/2016/023039A1
The invention provides compounds, compositions and therapeutic methods. The compounds and compositions can be used for the treatment of myotonic dystrophy. The compounds can selectively bind to CUG repeats in RNA, or to CTG repeats in DN...  
WO/2016/022965A1
Persistent carbene adducts and methods of forming the same are generally described, as well as compositions comprising the persistent carbene adduct. In some embodiments, methods are provided comprising heating a persistent carbene to re...  
WO/2016/007834A1
The present invention relates generally to topical antiviral compositions and methods of using the same.  
WO/2015/087857A1
Provided is an aryl amidine compound that has excellent bactericidal activity, is highly safe, can be synthesized in an industrially advantageous manner, and is represented by formula (II) or the like. Also provided is a bactericidal age...  
WO/2015/087834A1
The objective of the present invention is to provide a polyester resin composition which is free from the generation of an irritating gas in the production processes, and which is not increased in the viscosity of a polyester resin even ...  
WO/2015/012080A1
[Problem] To provide a novel polyimide polymer which is soluble in an organic solvent and to provide a novel synthetic method for a polyimide polymer which does not pass through a polyamic acid with a low storage stability. [Solution] A ...  
WO/2015/009195A1
The invention relates to novel substances, and more particularly to optical isomers of (+) and (-)-benzhydryl ureas of formula (I) and (+) and (-)-1-[(3-chlorophenyl)-phenyl-methyl] urea, a pharmaceutical composition based thereon, and a...  
WO/2014/157596A1
An amidine compound represented by formula (1) [wherein R1, R2, R3, R4 and R5 are the same as or different from one another, and independently represent a C1-C5 alkyl group which may have at least one halogen atom or the like; R6 and R7 ...  
WO/2014/089226A1
With the rise in resistance to antibiotics such as methicillin, there is a need for new drugs. The invention provides small molecules that inhibit cellular drug targets such as UPPS and FPPS by interacting with binding pockets, thereby p...  
WO/2014/064016A1
The present invention relates to a process for the preparation of 4-aminobenzoamidine (4-AMBA) salts of general formula (I), preferably the salts thereof with hydrochloric or hydrobromic acid, particularly preferred the dichloride salt.  
WO/2014/057466A1
The present invention relates to a method for preparing formamidines of formula (I) in a single step by reducing ureas of formula (II) using silanes of formula (III), according to reaction (II) + (III) + (I). The present invention also r...  
WO/2014/020350A1
Compounds of formula (I) or pharmaceutically acceptable salts, solvates or hydrates thereof wherein P, Q, X, Y, R1, R2, R3, R10, R11, and R12 are as defined in the claims, and the use those compounds in medicine.  
WO/2014/020351A1
N-(4-carbamimidoylphenyl)-amide derivatives having utility in therapy as PAR2 receptor antagonists.  
WO/2013/182993A1
The present invention relates to a method for preparing nitrogen compounds using carbon dioxide, and to the use of said method in the production of vitamins, pharmaceutical products, adhesives, acrylic fibres, synthetic leathers, pestici...  
WO/2013/090547A1
A compound of Formula (2) is disclosed: wherein R1, MA and MB are as defined in the disclosure. Also disclosed is a method for preparing a compound of Formula (1): wherein R1 and X are as defined in the disclosure comprising contacting a...  
WO/2013/062024A1
Provided is a plant disease control agent which, regardless of where employed, effectively controls a wide range of plant pathogens. This plant disease control agent contains, as an active component, a compound represented by formula (I)...  
WO/2013/051670A1
Provided is a technique making it easy to form a high-quality cobalt-based film which has a low melting point and is liquid at about 40°C, is unlikely to solidify and create a blockage midway in piping, and enables a stable supply of ra...  
WO/2013/034756A1
The present invention relates to a compound of formula (I), wherein R1 and R2 are independently selected from (a) C1 to C6 alkyl; C2 to C6 alkenyl; C2 to C6 alkynyl; substituted or unsubstituted heterocycloalkyl or cycloalkyl, substituen...  
WO/2013/026947A1
The invention relates to compounds formed by a small molecule that can bind to double-stranded DNA, covalently linked to a photolabile protecting group, and to the uses thereof. The deprotection of these compounds by means of light irrad...  
WO/2012/090969A1
An amidine compound represented by formula (1): wherein R1 represent a C1-C11 fluoroalkyl group, a C3-C11 fluoroalkenyl group or a C3-C11 fluoroalkynyl group; R2 represent a C1-C3 alkyl group; R3 represent a C1-C3 alkyl group; R4 represe...  
WO/2012/060401A1
The purpose of the present invention is to provide a novel chemical having an excellent fungicidal activity. The compound to be used as the chemical according to the present invention is an ethynylphenylamidine compound represented by ge...  
WO/2011/135142A1
The invention relates to compounds derived from bis-benzamidines as fluorogenic agents for signalling specific sequences of double-stranded DNA. The invention further relates to a group of compounds having a benzamidine structure, to a m...  
WO/2011/118672A1
Disclosed is a pharmaceutical product, particularly a pharmaceutical composition having a plasma kallikrein inhibition activity and is useful as a prophylactic or therapeutic agent for edemas (particularly hereditary vascular edema and c...  
WO/2011/073703A3
Process for the preparation of the compounds of the general formula (I) - where in the formula R represents cyano group, - COOR1 or -CONR2R3 group - where R1, R2 and R3 stand for identical or non-identical substituents chosen from the fo...  
WO/2011/061080A1
The invention relates to an improved method for producing dabigatran etexilate, and analogous compounds of the formula (7).  
WO/2011/050469A1
A solvent that reversibly converts from a hydrophobic liquid form to hydrophilic liquid form upon contact with water and a selected trigger, e.g., contact with CO2, is described. The hydrophilic liquid form is readily converted back to t...  

Matches 1 - 50 out of 1,761